IPCA Laboratories
quarterly
yearly
| Particulars | Mar '21 | Jun '21 | Sep '21 | Dec '21 | Mar '22 |
|---|---|---|---|---|---|
| Revenue | 1,115 | 1,566 | 1,544 | 1,430 | 1,289 |
| Expenses | 938.25 | 1,205 | 1,236 | 1,181 | 1,131 |
| EBITDA | 176.41 | 360.67 | 308.62 | 249.16 | 158.39 |
| EBIT | 123.91 | 304.80 | 251.66 | 190.51 | 97.45 |
| Profit Before Tax | 192.13 | 377.44 | 320.31 | 256.07 | 160.74 |
| Net Profit | 161.34 | 306.66 | 250.23 | 196.96 | 130.23 |
| Financial Ratios | |||||
| Operating Profit Margin | 15.83% | 23.03% | 19.98% | 17.42% | 12.29% |
| Net Profit Margin | 14.47% | 19.59% | 16.20% | 13.77% | 10.10% |
| Earning Per Share (Diluted) | 6.34 | 12.09 | 9.87 | 3.88 | 5.13 |
| Dividends Per Share | 4.00 | NA | 4.00 | NA | 8.00 |
